RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Paradigm Biopharmaceuticals Stock

Paradigm Biopharmaceuticals ROE 2025

Paradigm Biopharmaceuticals ROE

-0.89

Ticker

PAR.AX

ISIN

AU000000PAR5

In 2025, Paradigm Biopharmaceuticals's return on equity (ROE) was -0.89, a -6.56% increase from the -0.95 ROE in the previous year.

Paradigm Biopharmaceuticals Aktienanalyse

What does Paradigm Biopharmaceuticals do?

Paradigm Biopharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Paradigm Biopharmaceuticals's Return on Equity (ROE)

Paradigm Biopharmaceuticals's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Paradigm Biopharmaceuticals's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Paradigm Biopharmaceuticals's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Paradigm Biopharmaceuticals’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Paradigm Biopharmaceuticals stock

What is the ROE (Return on Equity) of Paradigm Biopharmaceuticals this year?

The ROE of Paradigm Biopharmaceuticals this year is -0.89 undefined.

How has the Return on Equity (ROE) of Paradigm Biopharmaceuticals developed compared to the previous year?

The ROE of Paradigm Biopharmaceuticals has increased by -6.56% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Paradigm Biopharmaceuticals?

A high ROE indicates that Paradigm Biopharmaceuticals generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Paradigm Biopharmaceuticals?

A low ROE can indicate that Paradigm Biopharmaceuticals is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Paradigm Biopharmaceuticals affect the company?

A change in ROE (Return on Equity) of Paradigm Biopharmaceuticals can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Paradigm Biopharmaceuticals?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Paradigm Biopharmaceuticals?

Some factors that can influence Paradigm Biopharmaceuticals's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Paradigm Biopharmaceuticals pay?

Over the past 12 months, Paradigm Biopharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Paradigm Biopharmaceuticals is expected to pay a dividend of 0 AUD.

What is the dividend yield of Paradigm Biopharmaceuticals?

The current dividend yield of Paradigm Biopharmaceuticals is .

When does Paradigm Biopharmaceuticals pay dividends?

Paradigm Biopharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Paradigm Biopharmaceuticals?

Paradigm Biopharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Paradigm Biopharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Paradigm Biopharmaceuticals located?

Paradigm Biopharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Paradigm Biopharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Paradigm Biopharmaceuticals from 10/9/2025 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 10/9/2025.

When did Paradigm Biopharmaceuticals pay the last dividend?

The last dividend was paid out on 10/9/2025.

What was the dividend of Paradigm Biopharmaceuticals in the year 2024?

In the year 2024, Paradigm Biopharmaceuticals distributed 0 AUD as dividends.

In which currency does Paradigm Biopharmaceuticals pay out the dividend?

The dividends of Paradigm Biopharmaceuticals are distributed in AUD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Paradigm Biopharmaceuticals

Our stock analysis for Paradigm Biopharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Paradigm Biopharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.